Substituted porphyrins

Details Substituted porphyrins Substituted porphyrins

2005-07-12

2005-07-12

Wilson, James O. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S184000, C514S185000, C540S145000

Reexamination Certificate

active

06916799

ABSTRACT:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.

REFERENCES:
patent: 2951799 (1960-09-01), Sharp
patent: 4614723 (1986-09-01), Schmidt
patent: 4657902 (1987-04-01), Kappas et al.
patent: 4746735 (1988-05-01), Kruper, Jr. et al.
patent: 4758422 (1988-07-01), Quay
patent: 4829984 (1989-05-01), Gordon
patent: 4837221 (1989-06-01), Bonnett
patent: 4851403 (1989-07-01), Picker et al.
patent: 4866054 (1989-09-01), Dori et al.
patent: 4885114 (1989-12-01), Gordon et al.
patent: 4892941 (1990-01-01), Dolphin et al.
patent: 4895719 (1990-01-01), Radhakrishnam
patent: 4963367 (1990-10-01), Ecanow
patent: 5010073 (1991-04-01), Kappas et al.
patent: 5051337 (1991-09-01), Sakoda et al.
patent: 5087438 (1992-02-01), Gordon
patent: 5109016 (1992-04-01), Dixon et al.
patent: 5130245 (1992-07-01), Marklund et al.
patent: 5162519 (1992-11-01), Bonnett
patent: 5169630 (1992-12-01), Okaya et al.
patent: 5171680 (1992-12-01), Mullenbach et al.
patent: 5192757 (1993-03-01), Johnson et al.
patent: 5192788 (1993-03-01), Dixon et al.
patent: 5202317 (1993-04-01), Bruice
patent: 5217966 (1993-06-01), Bruice
patent: 5223538 (1993-06-01), Fridovich
patent: 5227405 (1993-07-01), Fridovich
patent: 5236914 (1993-08-01), Meunier
patent: 5236915 (1993-08-01), Fiel
patent: 5248603 (1993-09-01), Marklund et al.
patent: 5262532 (1993-11-01), Tweedle et al.
patent: 5277908 (1994-01-01), Beckman et al.
patent: 5281616 (1994-01-01), Dixon et al.
patent: 5284647 (1994-02-01), Niedballa
patent: 5366729 (1994-11-01), Marklund et al.
patent: 5403834 (1995-04-01), Malfroy-Camine et al.
patent: 5405369 (1995-04-01), Selman et al.
patent: 5472691 (1995-12-01), Marklund et al.
patent: 5493017 (1996-02-01), Therien et al.
patent: 5563132 (1996-10-01), Bodaness
patent: 5599924 (1997-02-01), Therien et al.
patent: 5604199 (1997-02-01), Funanage
patent: 5610293 (1997-03-01), Riley et al.
patent: 5637578 (1997-06-01), Riley et al.
patent: 5674467 (1997-10-01), Maier et al.
patent: 5747026 (1998-05-01), Crapo
patent: 5767272 (1998-06-01), Wijesekera et al.
patent: 5834509 (1998-11-01), Malfroy-Camine et al.
patent: 5874421 (1999-02-01), Riley et al.
patent: 5948771 (1999-09-01), Danziger
patent: 5976498 (1999-11-01), Neumann et al.
patent: 5976551 (1999-11-01), Mottez et al.
patent: 5994339 (1999-11-01), Crapo et al.
patent: 5994410 (1999-11-01), Chiang et al.
patent: 6013241 (2000-01-01), Marchal et al.
patent: 6046188 (2000-04-01), Malfroy-Camine et al.
patent: 6060467 (2000-05-01), Buelow et al.
patent: 6084093 (2000-07-01), Riley et al.
patent: 6087493 (2000-07-01), Wheelhouse et al.
patent: 6103714 (2000-08-01), Fridovich et al.
patent: 6127356 (2000-10-01), Crapo et al.
patent: 6180620 (2001-01-01), Salvemini
patent: 6204259 (2001-03-01), Riley et al.
patent: 6214817 (2001-04-01), Riley et al.
patent: 6245758 (2001-06-01), Stern et al.
patent: 6372727 (2002-04-01), Crow et al.
patent: 6395725 (2002-05-01), Salvemini
patent: 6403788 (2002-06-01), Meunier et al.
patent: 6417182 (2002-07-01), Abrams et al.
patent: 6544975 (2003-04-01), Crapo et al.
patent: 6548045 (2003-04-01), Sakata et al.
patent: 6566517 (2003-05-01), Miura et al.
patent: 6602998 (2003-08-01), Kobuke et al.
patent: 6624187 (2003-09-01), Pandey et al.
patent: 2002/0058643 (2002-05-01), Cherian et al.
patent: 0 127 797 (1984-12-01), None
patent: 0 186 962 (1986-07-01), None
patent: 0 282 899 (1988-09-01), None
patent: 0 336 879 (1989-10-01), None
patent: 0 337 601 (1989-10-01), None
patent: 0 345 171 (1989-12-01), None
patent: 0 414 915 (1991-03-01), None
patent: 0 462 836 (1991-12-01), None
patent: 0 524 161 (1993-01-01), None
patent: 0 532 327 (1993-03-01), None
patent: 2 676 738 (1992-11-01), None
patent: 91/04315 (1991-04-01), None
patent: WO 91/04315 (1991-04-01), None
patent: WO 91/19977 (1991-12-01), None
patent: 92/07935 (1992-05-01), None
patent: WO 92/08482 (1992-05-01), None
patent: WO 92/15099 (1992-09-01), None
patent: WO 93/02090 (1993-02-01), None
patent: WO 94/04614 (1994-03-01), None
patent: WO 94/05285 (1994-03-01), None
patent: WO 95/10185 (1995-04-01), None
patent: WO 95/31197 (1995-11-01), None
patent: WO 96/09038 (1996-03-01), None
patent: WO 96/09053 (1996-03-01), None
patent: WO 96/40223 (1996-12-01), None
patent: WO 97/06824 (1997-02-01), None
patent: WO 97/06830 (1997-02-01), None
patent: WO 97/06831 (1997-02-01), None
patent: WO 97/33588 (1997-09-01), None
patent: WO 97/33877 (1997-09-01), None
patent: WO 98/33503 (1998-06-01), None
patent: WO 98/58636 (1998-12-01), None
patent: WO 99/23097 (1999-05-01), None
patent: WO 99/55388 (1999-11-01), None
patent: WO 00/04868 (2000-02-01), None
patent: WO 00/43395 (2000-07-01), None
patent: WO 00/72893 (2000-12-01), None
patent: WO 01/26655 (2001-04-01), None
patent: WO 01/96345 (2001-12-01), None
Davila et al. {J. Chem. Soc. Chem. Commun., (1987), 525-527}.
Bütje et al. {Inorg. Chim. Acta, 167 (1990) 97-108}.
Sari et al. {Biochemistry, 29, (1990), 4205-4215}.
Comhair et al. (Medline abstract) and Rosenfeld et al. (Medline abstract).
Vodizinskii et al. (Russ. J. Org. Chem. 34(6) 1998, 882-885.
Kaufmann et al. {Inorg. Chem. 34, (1995), 5073}.
Hambright {J. Inorg. Nucl. Chem. 39, (1997), 1102}.
Hambright et al. {Porphyrin Chem. Adv., Pap. Porphyrin Symp. (1979), Meeting Date 1977, 284-92}.
Batinic-Haberle et al, “TheOrthoEffect Makes Manganese(III) Meso-Tetrakis-(N-Methylpyridinium-2-yl)Porphyrin a Powerful and Potentially Useful Superoxide Dismutase Mimic”, The Journal of Biological Chemistry 273(38):24521-24528 (1998).
Inoue et al, “Expression of a Hybrid Cu/Zn-type Superoxide . . . ” J. Bio. Chem., vol. 266. No. 25. pp. 16409-16414 (1991).
Day et al. “Manganic Porphyrins Possess Catalase Activity . . . ,” Arch. Biochem. Biophys., vol. 347. No. 2. pp. 256-262 (1997).
Tsan. M-F., “Superoxide Dismutase and Pulmonary Oxygen Toxicity.” XP-002074505, pp. 286-290.
Naruta et al. (1991) J. Am. Chem. Soc. 113:3595-3596.
Leondiadis et al. (1989) J. Org. Chem. 54:6135-6138.
Foran et al. “Effect of Electrolyte Concentration on Axial Anion Ligation in Manganese(III) meso-Tetraphenylporphyrin Chlorides”. Inorg. Chem. 31:1463-1470 (1992).
Milgrom, Facile Aenal Oxidation of a Porphyrin. Part 3. Some Metal Complexes of meso-Tetrakis-(3,5-di-t-butyl-4-hydroxyphenyl)porphyrin. J. Chem. Soc. Perkin Trans. 11:71-79 (1988).
Bockhorst and Hoehn-Bertage, “An Optimized Synthesis of Manganese mesoTetra(4-sulfonato-phenyl)porphine: A Tumor-Selective MRI Contrast Agent”, Tetrahedron 50(29):8657-8660 (1994).
Keinan et al, “Catalytic Antibodies. Circular Dichroism and UV-Vis Studies of Antibody-Metalloporphyrin Interactions”. Inorg. Chem. 31:5433-5438 (1992).
Marx, “Role of Gene Defect in Heredity ALS Clarified”, Science 261:986 (1993).
Epp et al, “Superoxide Dismutase Activity of Manganese Chelates”, 76-78 (1986).
Bors et al, “An expanded function for superoxide dismutase”, Chemical Abstracts 115:388 (1991), Abstract No. 109185h.
Miigrom et al, “Redox Behaviour of Phenolic Porphyrins in Basic Solutions: A Reappraisal”, Free Rad. Res. 24(1):19-29 (1996).
Szabo et al, “Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger”, FEBS Letters 381:82-86 (1996).
Patel et al, “Requirement for Superoxide in Excitotoxic Cell Death”, Neuron 16:345-355 (1996).
Bamford et al, “The Squalestatins: Synthesis and Biological Activity of Some C3-Modified Analogues; Replacement of a Carboxylic Acid or Methyl Ester with an Isoelectric Heterocyclic Functionality”, J. Med. Che

Affiliated with

Also associated with

Rating

Substituted porphyrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted porphyrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted porphyrins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3381202